22531-06-2

Basic information

• Product Name: 7-Ethyl-1-tetralone
• Synonyms: 7-Ethyl-1-tetralone;7-ethyl-3,4-dihydro-2H-naphthalen-1-one;7-ethyl-3,4-dihydronaphthalen-1(2H)-one
• CAS NO: 22531-06-2
• Molecular Formula: C₁₂H₁₄O
• Molecular Weight: 174.23896
• Mol File: 22531-06-2.mol
• Article Data: 7

Chemical Properties

• Boiling Point: 265.23°C (rough estimate)
• Flash Point: 127.2°C
• Appearance: /
• Density: 1.0556
• Vapor Pressure: 0.00112mmHg at 25°C
• Refractive Index: 1.5599 (estimate)
• Storage Temp.: Sealed in dry,Room Temperature
• CAS DataBase Reference: 7-Ethyl-1-tetralone(CAS DataBase Reference)
• NIST Chemistry Reference: 7-Ethyl-1-tetralone(22531-06-2)
• EPA Substance Registry System: 7-Ethyl-1-tetralone(22531-06-2)

Safety Data

• Hazardous Substances Data: 22531-06-2(Hazardous Substances Data)

Usage

General Description

7-Ethyl-1-tetralone is a chemical compound with the molecular formula C12H16O. It is a ketone with a six-membered ring that contains a carbonyl group. 7-Ethyl-1-tetralone is used as an intermediate for the synthesis of various pharmaceuticals and organic compounds. It is also used in the production of fragrances and flavorings. 7-Ethyl-1-tetralone is a yellow liquid with a sweet, floral odor, and it has a boiling point of 245-250°C. It is considered to be a potential environmental contaminant and is subject to regulations on its use and disposal.

InChI:InChI=1/C12H14O/c1-2-9-6-7-10-4-3-5-12(13)11(10)8-9/h6-8H,2-5H2,1H3

Upstream product

• 5467-53-8 γ-(p-ethylphenyl)butyric acid 
• 855215-98-4 4-(4-ethyl-phenyl)-butyryl chloride 
• 7664-93-9 sulfuric acid 
• 855221-60-2 4-(4-ethylphenyl)butanenitrile 
• 49594-75-4 4-(4-ethylphenyl)-4-oxobutyric acid 

Downstream Products

• 22531-20-0 6-ethyltetralin 
• 6333-77-3 7-ethyl-3,4-dihydro-2H-naphthalen-1-one semicarbazone 
• 13112-58-8 7-ethyl-1-naphthol 
• 108299-80-5 2-(7-ethyl-1-oxo-1,2,3,4-tetrahydro-[2]naphthyl)-propionic acid 
• 126309-61-3 (+/-)-α-anilino-deoxybenzoin-seqcis-oxime 
• 144404-63-7 ethyl α,α-(4-methyl-2-ketocyclohexane)-γ-(7'-ethyl-1'-naphthyl)butanoate 
• 146550-61-0 α,α-(7-ethyltetralin)-γ-(p-methylphenyl)butyric acid 
• 146550-67-6 C₂₁H₂₁NO₂ 
• 146550-60-9 α,α-(7-ethyltetralin)-β-(p-methylbenzoyl) propionic acid 
• 13149-64-9 3-Hydroxy-2-<1-hydroxy-7-aethyl-naphthoyl-(2)>-benzoesaeure 
• 13243-90-8 6-Hydroxy-2-<1-hydroxy-7-aethyl-naphthoyl-(2)>-benzoesaeure 
• 13243-91-9 2-(4-Bromo-7-ethyl-1-hydroxy-naphthalene-2-carbonyl)-6-hydroxy-benzoic acid 
• 676133-21-4 (R)-7-ethyltetralin-1-ol 

Relevant articles and documents

Green synthesis method of medical intermediate benzocyclohexanone compound

The invention provides a green synthesis method of a benzocyclohexanone compound, and belongs to the technical field of organic synthesis. The method provided by the invention comprises the followingsteps: by taking 4-phenylbutyric acid as a raw material, firstly carrying out reflux reaction with oxalyl chloride in dichloromethane, carrying out vacuum evaporation to dryness to obtain a crude product of the 4-phenylbutyryl chloride compound, then dissolving the crude product in a solvent, adding a metal-doped modified molecular sieve catalyst to start reaction, and stirring the solution at different temperatures to carry out ring closing reaction, thereby obtaining the product; and after the reaction is finished, carrying out suction filtration, solvent washing, column chromatography purification and other operations to obtain the target product benzocyclohexanone compound. The synthesis method disclosed by the invention is environment-friendly in reaction and simple and convenient tooperate, the catalyst can be recycled, and the synthesis method is suitable for green synthesis of the benzocyclohexanone compound.

Optimization of Pyrazoles as Phenol Surrogates to Yield Potent Inhibitors of Macrophage Migration Inhibitory Factor

Macrophage migration inhibitory factor (MIF) is a proinflammatory cytokine that is implicated in the regulation of inflammation, cell proliferation, and neurological disorders. MIF is also an enzyme that functions as a keto–enol tautomerase. Most potent MIF tautomerase inhibitors incorporate a phenol, which hydrogen bonds to Asn97 in the active site. Starting from a 113-μm docking hit, we report results of structure-based and computer-aided design that have provided substituted pyrazoles as phenol alternatives with potencies of 60–70 nm. Crystal structures of complexes of MIF with the pyrazoles highlight the contributions of hydrogen bonding with Lys32 and Asn97, and aryl–aryl interactions with Tyr36, Tyr95, and Phe113 to the binding.

ARYL(ALKYL)PROPYLAMIDES

The invention relates to a compound selected from those of formula (I) : STR1 in which A, R 1, R' 1, R 2, R 3 and n are as defined in the description, and medicinal product containing the same useful for treating a mammal afflicted with a disorder of the